| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,488 |
4,217 |
$2.55M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,572 |
4,300 |
$409K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,342 |
1,286 |
$218K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,204 |
749 |
$137K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,667 |
1,582 |
$112K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,887 |
2,617 |
$80K |
| 36591 |
|
1,005 |
639 |
$72K |
| 80053 |
Comprehensive metabolic panel |
12,582 |
9,681 |
$72K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,189 |
2,041 |
$65K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
362 |
355 |
$61K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
688 |
658 |
$50K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,917 |
9,729 |
$43K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,321 |
4,003 |
$39K |
| 96367 |
|
429 |
299 |
$36K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,806 |
1,726 |
$34K |
| 70450 |
Computed tomography, head or brain; without contrast material |
704 |
679 |
$33K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
891 |
758 |
$27K |
| G0378 |
Hospital observation service, per hour |
390 |
376 |
$25K |
| 83880 |
|
2,234 |
1,983 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
1,381 |
1,328 |
$24K |
| 86832 |
|
510 |
438 |
$22K |
| 86833 |
|
480 |
433 |
$20K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
650 |
607 |
$19K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
759 |
634 |
$17K |
| 71045 |
Radiologic examination, chest; single view |
1,495 |
1,395 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,808 |
1,694 |
$15K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,478 |
1,178 |
$15K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
57 |
54 |
$15K |
| 83735 |
|
5,487 |
3,551 |
$14K |
| 84703 |
|
2,623 |
2,409 |
$14K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
96 |
64 |
$12K |
| 84484 |
|
3,322 |
1,934 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,490 |
1,344 |
$10K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
114 |
113 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,308 |
1,547 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
327 |
310 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
687 |
642 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,673 |
2,210 |
$7K |
| 83605 |
|
2,122 |
1,417 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
68 |
67 |
$7K |
| 86850 |
|
961 |
822 |
$6K |
| 87088 |
|
1,753 |
1,637 |
$6K |
| 99152 |
|
158 |
154 |
$6K |
| 87497 |
|
827 |
657 |
$5K |
| 96417 |
|
35 |
24 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
758 |
446 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,400 |
1,258 |
$5K |
| 80197 |
|
1,849 |
1,175 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,750 |
2,084 |
$4K |
| CP008 |
|
98 |
85 |
$4K |
| 85027 |
|
1,639 |
1,157 |
$4K |
| 84439 |
|
1,051 |
941 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
333 |
109 |
$4K |
| 85610 |
|
3,092 |
2,622 |
$4K |
| 71250 |
|
129 |
128 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
924 |
850 |
$4K |
| 85730 |
|
1,994 |
1,796 |
$3K |
| 87799 |
|
506 |
383 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,940 |
1,715 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,102 |
1,063 |
$3K |
| 76801 |
|
38 |
37 |
$3K |
| 81001 |
|
2,618 |
2,327 |
$3K |
| 81003 |
|
2,001 |
1,879 |
$3K |
| 84100 |
|
2,945 |
2,100 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
36 |
36 |
$3K |
| CP007 |
|
54 |
48 |
$2K |
| 83615 |
|
1,095 |
788 |
$2K |
| 83690 |
|
1,064 |
931 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
14 |
$2K |
| 85007 |
|
1,302 |
902 |
$2K |
| 83970 |
|
459 |
419 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
285 |
83 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
605 |
454 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,480 |
1,424 |
$2K |
| 80061 |
Lipid panel |
1,043 |
1,002 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,157 |
1,076 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
374 |
359 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
14 |
$2K |
| 87070 |
|
486 |
391 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
902 |
587 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
148 |
71 |
$2K |
| 87077 |
|
771 |
610 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
734 |
680 |
$1K |
| 87040 |
|
256 |
143 |
$1K |
| 86901 |
|
1,397 |
1,151 |
$1K |
| 86900 |
|
1,336 |
1,092 |
$1K |
| 82550 |
|
489 |
437 |
$1K |
| 86769 |
|
222 |
119 |
$878.59 |
| J1644 |
Injection, heparin sodium, per 1000 units |
475 |
329 |
$865.11 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
38 |
33 |
$845.58 |
| 87186 |
|
502 |
403 |
$789.56 |
| 87400 |
|
77 |
74 |
$775.48 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
291 |
255 |
$770.03 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
39 |
38 |
$738.84 |
| Q3014 |
Telehealth originating site facility fee |
152 |
144 |
$642.00 |
| 82728 |
|
298 |
277 |
$615.23 |
| 84702 |
|
61 |
56 |
$613.59 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
22 |
15 |
$437.19 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
797 |
545 |
$423.16 |
| 87340 |
|
168 |
156 |
$420.32 |
| 82077 |
|
75 |
69 |
$408.82 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,587 |
1,002 |
$404.79 |
| 82150 |
|
278 |
235 |
$401.67 |
| 82565 |
|
979 |
910 |
$376.32 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,619 |
1,313 |
$372.23 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
204 |
198 |
$337.76 |
| 86413 |
|
14 |
14 |
$303.76 |
| 82607 |
|
127 |
124 |
$299.64 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
726 |
620 |
$286.36 |
| 84550 |
|
389 |
308 |
$233.04 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,182 |
1,139 |
$198.79 |
| 83550 |
|
82 |
78 |
$168.41 |
| 82570 |
|
698 |
588 |
$164.97 |
| 96376 |
|
651 |
312 |
$164.28 |
| 36415 |
Collection of venous blood by venipuncture |
5,854 |
4,571 |
$161.45 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
25 |
25 |
$160.40 |
| 80076 |
|
126 |
106 |
$157.24 |
| 80179 |
|
14 |
13 |
$141.81 |
| 82746 |
|
42 |
41 |
$136.57 |
| 80143 |
|
14 |
13 |
$128.04 |
| 82805 |
|
17 |
12 |
$124.13 |
| 84156 |
|
717 |
602 |
$122.12 |
| 86140 |
|
156 |
144 |
$119.84 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
15 |
15 |
$117.90 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
15 |
12 |
$91.32 |
| 84132 |
|
292 |
261 |
$88.95 |
| C1769 |
Guide wire |
478 |
449 |
$76.34 |
| 88342 |
|
16 |
13 |
$74.96 |
| 83540 |
|
48 |
46 |
$69.58 |
| 82947 |
|
338 |
302 |
$60.93 |
| 81025 |
|
12 |
12 |
$53.72 |
| 85014 |
|
524 |
450 |
$48.91 |
| 90662 |
|
15 |
15 |
$41.36 |
| 0001A |
|
19 |
18 |
$39.94 |
| J2704 |
Injection, propofol, 10 mg |
1,561 |
1,191 |
$39.83 |
| 85651 |
|
80 |
76 |
$37.70 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
367 |
349 |
$19.61 |
| 0002A |
|
29 |
26 |
$15.18 |
| 84295 |
|
142 |
126 |
$13.48 |
| 82784 |
|
26 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
31 |
31 |
$0.00 |
| 93356 |
|
28 |
27 |
$0.00 |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
12 |
12 |
$0.00 |